NCT02665546View on ClinicalTrials.gov

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

December 31, 2018

Conditions
Langerhans Cell Histiocytosis
Trial Locations (1)

05303900

InCor Heart Institute, São Paulo

All Listed Sponsors
lead

InCor Heart Institute

OTHER

NCT02665546 - Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis | Biotech Hunter | Biotech Hunter